PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Immune checkpoint inhibition represents a major recent breakthrough in the treatment of malignant diseases including breast cancer. Blocking the programmed death receptor-1 (PD-...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 30,893
- Institution
- University of Tübingen
External Links
Identifiers
- ORCID
- 0000-0003-1227-1118
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.